Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | AGX | Common Stock | 12K | Dec 14, 2021 | Direct | ||||||
holding | AGX | Common Stock | 212 | Dec 14, 2021 | Held in Children's Trust | ||||||
holding | AGX | Common Stock | 188 | Dec 14, 2021 | Held in Children's Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AGX | Option to Purchase Common Stock | Award | $0 | +5K | +8.77% | $0.00 | 62K | Dec 14, 2021 | Common Stock | 5K | $37.13 | Direct | F1, F2, F3 |
transaction | AGX | Time-Based Restricted Stock Units | Award | $0 | +1.75K | $0.00 | 1.75K | Dec 14, 2021 | Common Stock | 1.75K | $0.00 | Direct | F4 |
Id | Content |
---|---|
F1 | On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022. |
F2 | As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; and (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and |
F3 | (g) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. |
F4 | On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024. |